Lacosamide Oral Solution
NDC 71921-411, Lacosamide Oral, solution, from Florida Pharmaceutical Products, LLC.
- Product NDC
- 71921-411
- Status
- Listed
- Labeler
- Florida Pharmaceutical Products, LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220386
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/71921-411 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71921-411-71 | 71921041171 | 1 BOTTLE in 1 CARTON (71921-411-71) / 200 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ba4e2e28-7dc3-47b3-9c2c-34e0b1f39fb8NADAC price for package 71921041171
GET /v1/drugs/nadac/71921041171
Use it
Look up 71921-411 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71921-411 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71921-411. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.